Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-09-18FDA Approved: FENTANYL SYSTEM — Supplemental Application (ALVOGEN)
FDA approved a supplemental application for the Fentanyl System by ALVOGEN, indicating continued authorization for this fentanyl transdermal…
-
FDA approval · 2018-09-18FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen, adding an additional generic product manufactured by S…
-
FDA approval · 2018-09-18FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental applications for HYDROCODONE BITARTRATE AND ACETAMINOPHEN from KVK-Tech, Inc., allowing the generic combination …
-
FDA approval · 2018-09-18FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
FDA approved a supplemental application for Oxymorphone hydrochloride from XLCare Pharmaceuticals, Inc., authorizing the marketing of a gene…
-
FDA approval · 2018-09-18FDA Approved: OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for oxycodone hydrochloride and acetaminophen (Elite Laboratories, Inc.), a generic opioid analgesic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-09-18FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for Elite Laboratories' methadone hydrochloride (ANDA 210484), authorizing its continued marketing a…
-
FDA approval · 2018-09-18FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2018-09-18FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for oxycodone hydrochloride from Epic Pharma, LLC, effectively authorizing the generic opioid an…
-
FDA approval · 2018-09-18FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for a hydrocodone bitartrate and acetaminophen product from Rhodes Pharmaceuticals L.P., confirming …
-
FDA approval · 2018-09-18FDA Approved: APADAZ — Supplemental Application (Zevra Therapeutics, Inc.)
FDA approved a supplemental application for APADAZ (benzhydrocodone and acetaminophen) from Zevra Therapeutics, Inc.
-
FDA approval · 2018-09-18FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)
FDA approved a supplemental application for Morphine Sulfate Extended Release from Rhodes Pharmaceuticals L.P., updating the product under a…
-
FDA approval · 2018-09-18FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for butorphanol tartrate submitted by Hikma Pharmaceuticals USA Inc., authorizing changes to the…
-
FDA approval · 2018-09-18FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for tramadol hydrochloride from Lupin Pharmaceuticals, Inc., approving an additional generic product…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief [NA]
Clinical trial evaluating Buzzy versus vapocoolant spray for pediatric needle pain relief has completed with posted results.
-
FDA approval · 2018-09-18FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Sun Pharmaceutical Industries.
-
FDA approval · 2018-09-18FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for hydrocodone bitartrate and acetaminophen from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2018-09-18FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)
FDA approved a supplemental ANDA for oxycodone hydrochloride from KVK-Tech, Inc., confirming regulatory authorization for the generic produc…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Study of Pain Control With Hormonal IUS Insertion [Phase 4]
A Phase 4 clinical trial assessing pain control during hormonal intrauterine system insertion has completed.
-
FDA approval · 2018-09-13FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Original Application (Aurolife Pharma, LLC)
The FDA approved Aurolife Pharma, LLC's generic hydrocodone bitartrate and acetaminophen tablet under an original application. The product p…
-
FDA approval · 2018-09-11FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Hydrocodone Bitartrate and Acetaminophen (a generic opioid analgesic), auth…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children [Phase 2]
Phase 2 trial comparing EMLA Cream to Synera Patch for reducing pain during venipuncture in children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain [Phase 4]
Exploratory Phase 4 trial investigating cognition and mobility in individuals with pain was terminated; results posted in 2018.
-
FDA approval · 2018-08-24FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for hydrocodone bitartrate and acetaminophen (Hikma Pharmaceuticals USA Inc.) to update/approve labe…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery [Phase 4]
Phase 4 clinical trial evaluating parasternal nerve block with bupivacaine for postoperative analgesia in children after cardiac surgery; re…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy [Phase 3]
A phase 3 trial assessing safety and efficacy of oxycodone HCl/niacin for pain after bunionectomy has completed with results posted.